Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

MIRZYME THERAPEUTICS LIMITED

Company number 10133310

Follow this company File for this company

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
15 Apr 2024 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Sub-division 26/01/2024
  • RES10 ‐ Resolution of allotment of securities
15 Apr 2024 SH02 Sub-division of shares on 26 January 2024
28 Sep 2023 AA Total exemption full accounts made up to 31 December 2022
18 Sep 2023 AP01 Appointment of Dr Malcolm Francis Barratt-Johnson as a director on 11 September 2023
18 Sep 2023 AP01 Appointment of Syed Sami Ahmad as a director on 11 September 2023
20 May 2023 MA Memorandum and Articles of Association
20 May 2023 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
05 May 2023 CS01 Confirmation statement made on 18 April 2023 with no updates
04 May 2023 RP04CS01 Second filing of Confirmation Statement dated 18 April 2019
04 May 2023 RP04SH01 Second filing of a statement of capital following an allotment of shares on 25 July 2018
  • GBP 100.036
26 Sep 2022 AA Total exemption full accounts made up to 31 December 2021
19 May 2022 CS01 Confirmation statement made on 18 April 2022 with no updates
28 Sep 2021 AA Total exemption full accounts made up to 31 December 2020
14 Aug 2021 TM01 Termination of appointment of Syed Omar Hayat as a director on 1 June 2021
02 May 2021 CS01 Confirmation statement made on 18 April 2021 with no updates
21 Dec 2020 AA Total exemption full accounts made up to 31 December 2019
24 Jul 2020 CS01 Confirmation statement made on 18 April 2020 with updates
30 Sep 2019 AA Total exemption full accounts made up to 31 December 2018
28 Jun 2019 CS01 18/04/19 Statement of Capital gbp 100.256
  • ANNOTATION Clarification a second filed CS01 (Statement of capital change and Shareholder information change) was registered on 04/05/2023
27 Jun 2019 SH01 Statement of capital following an allotment of shares on 22 December 2018
  • GBP 100.256
27 Jun 2019 SH01 Statement of capital following an allotment of shares on 9 November 2018
  • GBP 100.116
27 Jun 2019 SH01 Statement of capital following an allotment of shares on 12 October 2018
  • GBP 100.068
30 Apr 2019 AA01 Previous accounting period shortened from 30 April 2019 to 31 December 2018
23 Jan 2019 AA Total exemption full accounts made up to 30 April 2018
14 Nov 2018 AP01 Appointment of Michael Edwin Vousden as a director on 3 October 2018